Asthma Severity and Medications During Pregnancy: Multiple Perspectives
Monday, March 5, 2018: 3:30 PM-4:45 PM
Convention Center, South Concourse, Level 2, S220B
1.25 CME/CE
Michael Schatz, MD MS FAAAAI

Learning Objectives:
  1. Discuss how cohort and database studies can address asthma medication safety during pregnancy as well as take into consideration asthma severity and control
  2. Describe the regulatory perspective regarding obtaining and disseminating information regarding the safety of asthma medications during pregnancy
  3. Discuss the international perspective regarding the safety and use of asthma medications during pregnancy
3:30 PM
Evaluating Asthma Medication Safety During Pregnancy: The VAMPSS Study Perspective
Christina D. Chambers, PhD MPH
3:50 PM
Question & Answer
3:55 PM
Obtaining and Disseminating Information Regarding Asthma Medication Safety During Pregnancy: A US Regulatory Perspective
Melissa S Tassinari, PhD DABT
4:15 PM
Question & Answer
4:20 PM
Asthma Medication Safety and Use During Pregnancy: An International Perspective
Vanessa E. Murphy, PhD
4:40 PM
Question & Answer
See more of: Session